Status:
COMPLETED
LDN and tDCS in Fibromyalgia
Lead Sponsor:
Centro Universitario La Salle
Collaborating Sponsors:
Hospital de Clinicas de Porto Alegre
Conditions:
Fibromyalgia
Eligibility:
FEMALE
8-65 years
Phase:
PHASE2
PHASE3
Brief Summary
Fibromyalgia is a complex generalized and diffuse musculoskeletal chronic pain; and pharmacological approaches are widely used to relieve pain and increase life quality. In this context, low-dose nalt...
Eligibility Criteria
Inclusion
- signed the consent form
- women from 18 to 65 years
- confirmed diagnosis of fibromyalgia according 2016 American College of Rheumatology criteria
- read and write
- pain higher than 6 in the Visual Analogue Scale (VAS), in the last 3 months
- chronic stable treatment in the last 3 months.
Exclusion
- in use of opioid drugs;
- pregnancy or not using anticontraceptive
- history of alcohol or drug abuse in the last 6 months
- history of neurological pathologies
- history of arrhythmia
- history of use of drugs that might change vascular response
- history of head trauma
- history of neurosurgery
- decompensated systemic diseases or chronic inflammatory diseases (lupus, rheumatoid arthritis, Sjogren syndrome, Reiter syndrome)
- history of non-compensated hypothyroidism
- personal history of cancer.
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT04502251
Start Date
August 1 2018
End Date
July 1 2020
Last Update
August 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade La Salle
Canoas, Rio Grande do Sul, Brazil, 92010-000